Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Amyndas Pharmaceuticals S.A.
BioCentury | Feb 8, 2023
Data Byte
Competition heats up in PNH with new Roche data
A dozen complement inhibitors behind Roche’s crovalimab also hope to challenge established therapies
BioCentury | Aug 11, 2017
Regulation
Foundation for inclusion
How the National Kidney Foundation is driving patient-centric R&D
BioCentury | Aug 4, 2017
Politics & Policy
National Kidney Foundation holding patient-focused meeting with FDA
BioCentury | Feb 10, 2014
Emerging Company Profile
Amyndas: Complement shutdown
Amyndas developing super compstatins for complement-mediated disorders
Items per page:
1 - 5 of 5